Cite
HPV integration: a precise biomarker for detection of residual/recurrent disease after treatment of CIN2-3.
MLA
Huang, Fanwei, et al. “HPV Integration: A Precise Biomarker for Detection of Residual/Recurrent Disease after Treatment of CIN2-3.” Infectious Agents & Cancer, vol. 19, no. 1, Aug. 2024, pp. 1–9. EBSCOhost, https://doi.org/10.1186/s13027-024-00600-8.
APA
Huang, F., He, L., Li, W., Huang, X., Zhang, T., Muaibati, M., Zhou, H., Chen, S., Yang, W., Yang, F., Zhuang, L., & Hu, T. (2024). HPV integration: a precise biomarker for detection of residual/recurrent disease after treatment of CIN2-3. Infectious Agents & Cancer, 19(1), 1–9. https://doi.org/10.1186/s13027-024-00600-8
Chicago
Huang, Fanwei, Liang He, Wei Li, Xiaoyuan Huang, Tao Zhang, Munawaer Muaibati, Hu Zhou, et al. 2024. “HPV Integration: A Precise Biomarker for Detection of Residual/Recurrent Disease after Treatment of CIN2-3.” Infectious Agents & Cancer 19 (1): 1–9. doi:10.1186/s13027-024-00600-8.